Treatment of acute promyelocytic leukaemia
- 31 March 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 14 (1) , 153-174
- https://doi.org/10.1053/beha.2000.0121
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- 6 Treatment of acute promyelocytic leukaemiaBailliere's Clinical Haematology, 1996
- Reassessing the hemostatic disorder associated with acute promyelocytic leukemia [see comments]Blood, 1992
- The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RARCell, 1991
- Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PMLCell, 1991
- Beneficial effect of heparin in the management of patients with APLBritish Journal of Haematology, 1988
- Acute promyelocytic leukemia.Therapy results and prognostic factorsCancer, 1988
- Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?Blood, 1987
- Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemiaThe American Journal of Medicine, 1984
- A Variant Form of Hypergranular Promyelocytic Leukemia (M3)Annals of Internal Medicine, 1980
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976